Kangzhong Medical: Plans to acquire the controlling stake of AI medical company Maide Intelligent through cash purchase

Mars Finance News, April 14: Kangzhong Medical announced that the company has adjusted its previously disclosed outbound investment plan. The company intends to acquire control of Mi De Intelligent Technology ( Wuxi ) Co., Ltd. by paying in cash. Following discussions, the target company’s overall valuation is 750 million yuan. If the company successfully acquires the equity held by the state-owned shareholder Liangxi Venture Capital, the company will hold 51% of the target company’s shares; if it is unable to acquire, it will acquire the equity of other shareholders, ultimately holding 50.7355% of the shares. The transaction funds will come from the company’s own funds and bank loans. The target company is a high-tech enterprise specializing in the research, development, and transformation of artificial intelligence medical big data algorithms. Its core business includes an AI real-time auxiliary diagnosis system for multiple diseases based on ultrasound imaging, and an AI bioinformatics analysis platform based on genomics. (Company Announcement)